Practical guidelines

Treatment of arrhythmogenic right ventricular cardiomyopathy (dysplasia)

M.Т. Vatutin¹, ², G.S. Smyrnova¹, Y.V. Yeshchenko¹, G.E. Degtiarova¹, V.S. Kolesnikov², Y.P. Gritsenko¹

¹ M. Gorky Donetsk National Medical University, Ukraine
² Institute of Urgent and Recovery Surgery named after V.K. Gusak of NAMS of Ukraine, Donetsk, Ukraine

Arrhythmogenic right ventricular cardiomyopathy (dysplasia) is an inheritable heart muscle disease predisposing to ventricular arrhythmias and increasing risk of sudden cardiac death. The accumulated data about clinical course, risk factors and therapeutic approaches allow to improve disease management. Review of the International Task Force Consensus Statement 2015 about treatment of arrhythmogenic right ventricular cardiomyopathy (dysplasia) is provided in this article. The information about risk stratification, follow-up, lifestyle changes, pharmacological therapy, catheter ablation, implantable defibrillator therapy and heart transplantation is given in detail. 

Key words: arrhythmogenic right ventricular cardiomyopathy, arrhythmogenic right ventricular dysplasia, treatment.